The Thrombectomy Devices Market is expected to witness significant growth in the coming years, driven by factors such as increasing prevalence of cardiovascular diseases, rising geriatric population, and advancements in technology leading to the development of innovative thrombectomy devices.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product Type, End-use Type |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Abbott Laboratories, Acandis, Angio Dynamics, Boston Scientific, Cook Medical, Edwards Lifesciences, Johnsen & Johnsen Services, Koninklijke Philips NV, Lemaitre Vascular, Medtronic Plc., Penumbra, Stryker, Teleflex Incorporated, Terumo, Weigao Group |
The high cost associated with thrombectomy procedures and devices is a major restraint for the market. Additionally, limited awareness about thrombectomy procedures among healthcare professionals and patients could hinder market growth in the foreseeable future.